[No general recommendation for waiving consolidated radiotherapy in Hodgkin lymphoma and negative PET results after completion of chemotherapy]

Strahlenther Onkol. 2016 Aug;192(8):595-6. doi: 10.1007/s00066-016-1000-1.
[Article in German]
No abstract available

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Bleomycin / therapeutic use
  • Combined Modality Therapy
  • Dacarbazine / therapeutic use
  • Disease Progression
  • Doxorubicin / therapeutic use
  • Female
  • Follow-Up Studies
  • Hodgkin Disease / mortality*
  • Hodgkin Disease / pathology
  • Hodgkin Disease / therapy*
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Positron-Emission Tomography / methods*
  • Prevalence
  • Proportional Hazards Models
  • Recurrence
  • Survival Analysis
  • Survival Rate
  • Treatment Outcome
  • United Kingdom / epidemiology
  • Vinblastine / therapeutic use
  • Young Adult

Substances

  • Bleomycin
  • Vinblastine
  • Dacarbazine
  • Doxorubicin

Supplementary concepts

  • ABVD protocol